Susquehanna International Group
VRNA

Susquehanna International Group’s Verona Pharma VRNA Stock Holding History

Susquehanna International Group’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-227,800
Closed -$24.3M – 13732
2025
Q3 		$24.3M Sell
227,800
-193,600
-46% -$20.2M ﹤0.01% 1998
2025
Q2 		$39.9M Sell
421,400
-54,800
-12% -$4.06M 0.01% 1333
2025
Q1 		$30.2M Buy
476,200
+255,600
+116% +$15.3M 0.01% 1381
2024
Q4 		$10.2M Sell
220,600
-18,700
-8% -$702K ﹤0.01% 2636
2024
Q3 		$6.88M Buy
239,300
+215,100
+889% +$5.29M ﹤0.01% 3114
2024
Q2 		$350K Sell
24,200
-22,000
-48% -$321K ﹤0.01% 9117
2024
Q1 		$743K Buy
46,200
+100
+0.2% +$1.73K ﹤0.01% 7574
2023
Q4 		$916K Buy
46,100
+8,000
+21% +$118K ﹤0.01% 7192
2023
Q3 		$621K Sell
38,100
-15,300
-29% -$295K ﹤0.01% 7724
2023
Q2 		$1.13M Buy
53,400
+1,800
+3% +$38.4K ﹤0.01% 6395
2023
Q1 		$1.04M Sell
51,600
-107,300
-68% -$2.32M ﹤0.01% 6722
2022
Q4 		$4.15M Sell
158,900
-143,400
-47% -$1.91M ﹤0.01% 3518
2022
Q3 		$3.09M Buy
302,300
+256,000
+553% +$2.16M ﹤0.01% 4023
2022
Q2 		$194K Buy
+46,300
New +$198K ﹤0.01% 10688

Other funds holding VRNA

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Susquehanna International Group's VRNA Position: Q2 2025 in Review

Susquehanna International Group sold out of Verona Pharma (VRNA) in Q2 2025, closing a stake of 33,655 shares — an estimated $2.49M sold.

Susquehanna International Group first reported a position in VRNA in Q4 2019 and held it in 12 quarters. The position peaked at $5.17M in Q4 2024. 292 funds tracked by Wall St. Rank hold VRNA as of Q2 2025.

  • Susquehanna International Group reported no remaining Verona Pharma position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 33,655 Verona Pharma shares in Q2 2025, an estimated $2.49M.
  • Susquehanna International Group first reported a position in Verona Pharma in Q4 2019 and held it in 12 quarters.
  • Susquehanna International Group's Verona Pharma position peaked at $5.17M in Q4 2024.
  • 292 funds tracked by Wall St. Rank held Verona Pharma as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.